Professor Udaya K. Ranawaka MBBS, MD, MRCP, FRCP (Lond), FCCP, FAHA, FAAN Professor Udaya Ranawaka is Professor in Neurology at the University of Kelaniya, and Honorary Consultant Neurologist and Head of the Stroke Unit and at the Colombo North Teaching Hospital, Ragama, Sri Lanka. He is a Fellow of the Ceylon College of Physicians, Royal College of Physicians of London, American Stroke Association and the American Academy of Neurology. He is a Past President of the National Stroke Association of Sri Lanka, Association of Sri Lankan Neurologists and the Ceylon College of Physicians. He is the Administrator of the Sri Lanka Clinical Trials Registry and is a Member of the Advisory Group of the International Clinical Trials Registry Platform, World Health Organisation. His main research interests include stroke, CNS infections, tropical neurology and clinical trial registration. He has been a National Coordinator/Principal Investigator in several international clinical trials and research collaborations on stroke. He has won over 30 national and international research awards. He has delivered eight named orations and over 100 invited lectures at national and international scientific meetings. He has several book chapters, over 80 journal publications and over 90 research abstracts to his credit.

Dr. Sujan Reddy is a board certified vascular neurologist who graduated from the University of Texas Health Science Center program in 2020, and is currently a practicing neurohospitalist in Fort Smith, Arkansas. His research interests include expanding access to acute stroke care via telemedicine, acute stroke imaging for thrombectomy selection and cerebrovascular complications in COVID-19.

Dr. Reddy is a premier cardiac electrophysiologist, and has developed and tested advanced therapies for cardiac arrhythmias and heart failure, including catheter ablation for atrial fibrillation and ventricular tachycardia, and device therapies for stroke prevention. Under his leadership, Mount Sinai is the lead investigational site for many multinational clinical trials exploring novel therapies, most recently pulsed field ablation to treat atrial fibrillation. Moreover, in 2014, he implanted the world’s first miniature leadless pacemaker, as well as the first leadless pacemaker in the United States at The Mount Sinai Hospital.

Marc Ribo is an interventional neurologist from Hospital Vall d’Hebron in Barcelona that underwent a vascular neurology fellowship at University of Texas-Houston (2004-5). His research work over the last 20 years was focused on improving access and efficacy of reperfusion treatments for acute stroke. He has a special interest in coordinating acute stroke management at the prehospital setting, integrating prehospital scales, telemedicine systems and artificial intelligence based solutions. He is the Co-Pi of the RACECAT study. He also has a special interest in improving in hospital workflows such as direct transfer to angio-suite (CO-PI of the ANGIOCAT and WE TRUST studies). He contributed to the growth of endovascular treatment of stroke exploring new selection protocols and novel devices. He is the Co-founder of Anaconda Biomed and Nora Health.

Gabriel J.E. Rinkel is professor of Neurology at the University Medical Center Utrecht in the Netherlands and visiting professor at the Department of Neurosurgery at the University Hospital Mannheim, University of Heidelberg in Germany. In 1991 he finished his training in neurology and defended his PhD thesis on perimesencephalic subarachnoid haemorrhage. His research is focussed on subarachnoid haemorrhage and intracranial aneurysms, on which he has published more than 500 papers in international peer reviewed journals. He has given lectures at more than 30 universities in 4 continents, is a regular invited speaker at many international conferences. He is fellow of the Royal College of Physicians in Edinburgh (UK) and has an honorary doctorate at the University of Eastern Finland (Kuopio).